List of works - H. Barton Grossman

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

scientific journal article

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

scientific article

A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer

scientific article

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

scientific article

Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin

scientific article

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

scientific article

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

scientific article

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

scientific article

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

scientific article

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

scientific article published on 09 January 2014

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) ⬇️

scientific article published on November 24, 2010

Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells ⬇️

scientific article published on March 17, 2011

Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer

scientific article

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

scientific article published in August 2004

Focus on bladder cancer

scientific article published in August 2004

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

scientific article published on 2 August 2009

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

scientific article

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients

scientific article

Genome-wide association study identifies multiple loci associated with bladder cancer risk

scientific article (publication date: March 2014)

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

scientific article

If cystectomy is insufficient, what is an urologist to do?

scientific article published on November 2003

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

journal article published in 2014

Innovation in Bladder Cancer Immunotherapy

scientific article published on 13 July 2016

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk ⬇️

scientific article published on March 6, 2012

Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy ⬇️

scientific article published on May 12, 2012

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression

scientific article

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

scientific article

Malignant mesothelioma of the tunica vaginalis

scientific article

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

scientific article published on 15 September 2016

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

scientific article published on July 2007

Neoadjuvant chemotherapy for bladder cancer

scientific article published on November 2003

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

scientific article published on 17 April 2012

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

scientific article

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

scientific article

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience

scientific article published on August 2007

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

scientific article published on 09 October 2008

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

scientific article published on 10 April 2007

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

scientific article

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

scientific article published on February 26, 2011

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

scientific article published on 04 May 2009

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

scientific article

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

scientific article published on 27 July 2017

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

scientific article

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

scientific article

Recent developments in the treatment of bladder cancer.

scientific article published on January 2003

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

scientific article

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study

scientific article

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

scientific article

Selective COX-2 inhibitors as chemopreventive and therapeutic agents.

scientific article

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease

scientific article published in October 2014

The International Bladder Cancer Bank: proposal for a new study concept

scientific article

The International Bladder Cancer Network.

scientific article published in July 2010

The role of radical cystectomy in patients with clinical T4b bladder cancer

scientific article

Tumor suppressor genes of bladder cancer and potential for gene therapy.

scientific article published on January 2003

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy

scientific article

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️

scientific article published on January 15, 2012

List of works by H. Barton Grossman

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) ⬇️

Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells ⬇️

Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

Focus on bladder cancer

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients

Genome-wide association study identifies multiple loci associated with bladder cancer risk

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

If cystectomy is insufficient, what is an urologist to do?

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Innovation in Bladder Cancer Immunotherapy

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk ⬇️

Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy ⬇️

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Malignant mesothelioma of the tunica vaginalis

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

Neoadjuvant chemotherapy for bladder cancer

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Recent developments in the treatment of bladder cancer.

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

Selective COX-2 inhibitors as chemopreventive and therapeutic agents.

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease

The International Bladder Cancer Bank: proposal for a new study concept

The International Bladder Cancer Network.

The role of radical cystectomy in patients with clinical T4b bladder cancer

Tumor suppressor genes of bladder cancer and potential for gene therapy.

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️